A recent New York Times editorial about the Food and Drug Administration reflects a systematic weakness at the once-venerable Gray Lady: The members of the editorial board often rely on sloganeering and popular wisdom instead of substantive evidence.
The editorial was headlined, "The FDA Is in Trouble. Here's How to Fix It." The agency is in trouble. But it's due to the very kinds of "fixes" the Times recommends.
The FDA's failures are a result of too much regulatory dithering and bureaucracy. Yet the Times' prescriptions for change would just increase the dose.
To read the entire article, please go to thefederalist.com/2020/01/20/yes-the-fda-is-in-trouble-but-the-new-york-times-prescription-would-make-it-worse/